Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05291156
Title CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Campania Luigi Vanvitelli
Age Groups: senior | adult
Covered Countries ITA

Additional content available in CKB BOOST